Pyoderm

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pyoderm

Property Description
Active Ingredient Chlorhexidine Gluconate
Form Topical Liquid (Solution, Shampoo, Wash)
Pharmacological Class Antiseptic, Germicide
Route of Administration Topical (Dermal)
Origin Synthetic Bis-Guanide Compound

Defining the Drug Entity and Pharmacological Class

Pyoderm is a pharmaceutical preparation whose active ingredient is Chlorhexidine Gluconate, an effective antiseptic and germicide belonging to the Dermatologic Agents class. The compound itself is synthetic, categorized chemically as a cationic bis-guanide. This classification establishes the medicine's core role as an agent for managing microbial populations on the skin surface.

Chlorhexidine Gluconate is utilized for topical decontamination, demonstrating broad-spectrum antimicrobial activity. This characteristic allows the compound to promote a hygienic environment on the skin. Pyoderm is typically available as an over-the-counter (OTC) product in its liquid formulations, positioning it as an accessible item for hygiene maintenance.

Composition, Forms, and General Therapeutic Purpose

Pyoderm is typically manufactured as a topical liquid, most commonly formulated as a solution, specialized shampoo, or wash for external dermal application only. This composition classifies it as a single-agent product within an aqueous base. The inherent therapeutic purpose of Pyoderm is to leverage its antimicrobial properties to promote and sustain skin hygiene.

Key Feature: Sustained Dermal Activity

A principal distinguishing characteristic of Chlorhexidine Gluconate is the property known as substantivity. This feature refers to the compound’s ability to adhere to the skin and mucous membranes due to its cationic charge.

This adherence allows the antiseptic effect to be maintained for a period after the product has been applied and rinsed away. This sustained action is a core attribute of the medicine's identity, providing support for dermatological hygiene unlike agents that have only immediate effects.

Regulatory References

  1. Chlorhexidine Gluconate topical label (DailyMed)

What side effects are possible with Pyoderm?

The safety characteristics of topical Chlorhexidine Gluconate formulations, such as Pyoderm, are defined primarily by the potential for dermal and systemic reactions, according to official regulatory documents.

Adverse reactions are officially classified within System Organ Classes (SOC), mainly concerning Immune System Disorders and Skin and Subcutaneous Tissue Disorders. These documented effects include localized manifestations such as skin irritation and the development of allergic contact dermatitis.

A serious adverse reaction, classified as rare by regulatory authorities, is anaphylaxis, which represents a severe, potentially systemic hypersensitivity reaction. Other serious consequences documented in the official labeling include the development of a chemical burn, a risk explicitly noted in certain populations, particularly premature infants.

The product is contraindicated for use in individuals with a known hypersensitivity or allergy to Chlorhexidine Gluconate. Administration-agnostic safety constraints also restrict the product’s use from highly sensitive internal tissues. Official labeling states that the solution must not be used in the meninges or instilled into the middle ear due to documented neurotoxicity risk. Furthermore, the solution is not to be used for preoperative skin preparation of the head or face to minimize the risk of eye and mucous membrane exposure. These classifications reflect how government regulatory documents organize and communicate the medicine's safety profile.

Overdose and Emergency Response

The regulatory overdose profile for topical preparations containing Chlorhexidine Gluconate (Pyoderm) is centered on the risks associated with accidental or intentional oral ingestion of concentrated solutions. Regulatory documentation emphasizes this route because systemic absorption through intact skin is minimal.

Documented Overdose Manifestations

Official regulatory sources document that ingestion may lead to signs of systemic toxicity, including Central Nervous System (CNS) depression, nausea, vomiting, and dyspnea (difficulty breathing). These clinical presentations can potentially escalate to severe, life-threatening outcomes, most notably respiratory failure.

When to Seek Immediate Medical Help

In the event of known or suspected ingestion, regulatory labeling mandates immediate emergency action. Individuals must seek immediate medical attention and contact a Poison Control Center or emergency medical services without delay. If the product accidentally contacts the eyes, the affected area must be thoroughly washed with water, and urgent medical help must be sought.

Management and Monitoring

The official management approach for overdose is defined as symptomatic and supportive treatment. Regulatory bodies state that no specific antidote is known for Chlorhexidine Gluconate overdose. Clinical supervision and close monitoring are required, specifically to observe for signs of respiratory compromise or deepening CNS depression. Procedural steps like gastric lavage may be considered in a supervised clinical setting.

Therapeutic Uses of Pyoderm

What Pyoderm Treats: Main Uses and Benefits

The topical liquid formula, containing Chlorhexidine Gluconate, is considered relevant support in therapeutic areas involving dermal antisepsis and the management of skin conditions where microbial load is the primary issue. Its utility plays a role in two main therapeutic domains: reducing surface microorganisms and supporting efforts to prevent related complications. Its established uses include general skin cleansing, patient preoperative skin preparation, and cleansing superficial skin wounds.


Symptom Management and Infection Control

This product is commonly used to help manage the symptoms of conditions like superficial bacterial pyoderma and other skin issues where bacterial or fungal overgrowth creates noticeable physiological strain. It is used to help with visible, localized manifestations such as pustules, crusting, scaling, and associated redness or inflammatory states. By applying it in situations involving certain distressing symptoms related to microbial proliferation, it offers symptomatic support that contributes to the easing of discomfort and helps maintain a sense of stability during acute or recurrent episodes.

The solution is also commonly used in clinical and real-world scenarios requiring proactive skin disinfection, assisting with minimizing the risk of subsequent infection at compromised sites. Its use supports efforts to maintain a reduced microbial burden.

Quick Fact: Relief for Microbial Symptoms
Main Therapeutic Benefit: Provides support that helps ease the overall symptom burden caused by surface microbial overgrowth.
Clinical Relevance: Used when managing conditions characterized by periods of heightened symptoms and associated skin lesions.

In institutional settings, it is commonly used for patient preoperative skin preparation, providing the benefit of pre-procedural antisepsis that is relevant when supportive symptom management and infection control are appropriate before medical procedures. This application supports general well-being during symptomatic phases and assists with maintaining functional stability by maintaining a lower microbial burden prior to procedures.

Regulatory References

  1. DailyMed official labeling for Antiseptic Skin Cleanser

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility for Pyoderm

Regulatory documents define specific populations that can or cannot use Pyoderm (Chlorhexidine Gluconate topical solution). Use is absolutely contraindicated in patients with a known history of hypersensitivity (allergy) to Chlorhexidine Gluconate or any ingredient in the formulation.

Age-Related and Conditional Use

Population Group Regulatory Status
Approved for Use Adults, teenagers, and children 2 months of age and older.
Not Recommended Children younger than 2 months of age (due to potential for increased absorption and irritation).
Pregnancy Status FDA Category B. Use during pregnancy is conditional and should occur only if clearly needed.

Eligibility-Related Restrictions

Regulatory labeling specifies that Pyoderm is not for use in contact with the meninges or on wounds that involve more than the superficial layers of skin. Furthermore, it must not be used as a preoperative skin preparation on the head or face, and application to the genital or anal areas is prohibited. There are no specific restrictions documented for topical use related to hepatic or renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes the officially documented interaction profile for the topical liquid formulation of Chlorhexidine Gluconate (Pyoderm), which is consistent with its use as an antiseptic and its minimal systemic absorption.

Pharmacodynamic Incompatibility

Regulatory documentation establishes that the active ingredient is chemically incompatible with anionic agents, including common substances like soaps and anionic surfactants. This reaction is a pharmacodynamic inactivation that results in the precipitation of the cationic active ingredient, leading to a loss of its intended antimicrobial efficacy.

Interaction Type Interacting Substance/Agent Regulatory Condition
Inactivation (Loss of Efficacy) Anionic Agents (Soaps, Surfactants) Must be avoided or used at a separate time.
Chemical Reaction (Residue) Hypochlorite Bleaches May cause brown staining on fabrics previously exposed to the product.

Due to this documented incompatibility, simultaneous or immediate successive use of anionic-containing products must be avoided to ensure the maintenance of the product’s function. Regulatory sources report the absence of systemic pharmacokinetic interactions, such as those mediated by CYP enzymes or drug transporters, which aligns with the product's minimal absorption into the bloodstream from the topical route.

Mechanism of Action

The mechanism of Pyoderm (Chlorhexidine Gluconate) is defined by a rapid, non-specific physical-chemical interaction with microorganisms, resulting in the reduction of the local microbial population due to the persistent nature of the mechanism.

Cationic Disruption of the Microbial Cell Membrane

The drug works by electrostatic binding to the negatively charged components of the microbial cell membrane (bacteria and fungi). This cationic attraction destabilizes the membrane, acting as a physical disruptor. This action compromises the cell's integrity, leading to the rapid leakage of small molecules and subsequent penetration of the drug, which causes coagulation and inactivation of vital intracellular proteins. The mechanistic consequence is a direct and rapid cytotoxicity against the targeted organisms.

Substantivity and Sustained Dermal Activity

A key mechanistic feature is substantivity, where the cationic drug adheres strongly to the anionic sites on the keratin found in the skin's outer layer. This binding creates a stable mechanistic reservoir on the dermal surface. This reservoir allows for the slow, continuous release of the active agent, which prolongs the antimicrobial action. This persistence of the active agent contributes to an effect profile characterized by prolonged lowering of the microbial burden on the skin surface, which continues after the initial rinse.

Dosage and Administration Information

The antiseptic preparation based on Chlorhexidine Gluconate is intended for application strictly via the topical route, designated for external use only on the skin surface. Its usage is standardized through protocols that govern the amount, duration, and sequence of application, depending on the purpose.


For routine hand washing in healthcare settings, a fixed volume, typically about 5 mL of the solution, is applied. This involves washing vigorously for 15 to 30 seconds, which is then immediately followed by a thorough rinse with water. A more intensive schedule is mandated for the surgical hand scrub, which requires two separate applications, each using approximately 5 mL of solution and scrubbing for up to 3 minutes before rinsing.

When the liquid is used for pre-operative skin preparation, the application must be allowed to air dry completely before the site is covered. For general skin cleansing, the instruction is to apply only the minimum amount necessary to fully cover the targeted area and then rinse. These professional-use solutions are generally intended to be applied undiluted.

Regarding specific populations, the product is not recommended for use in children younger than 2 months of age. A crucial procedural constraint for all administration is the explicit instruction to keep the liquid out of sensitive areas, including the eyes, ears, and mouth. Additionally, the solution must not be used on deep or puncture wounds.

Recent Clinical Evidence

Research evidence / Overview of Studies for Pyoderm

Evidence for use in General Dermal Antisepsis

The core research for topical Pyoderm, which contains chlorhexidine gluconate, focuses on research exploring the change in surface microbial load. This was studied for its primary function as an antiseptic. Clinical simulation studies and Randomized Controlled Trials (RCTs) were evaluated in these research efforts, primarily measuring the quantitative change in bacterial counts on the skin of healthy adult volunteers.

Studies monitored how the solution performed on microbial counts immediately after application. Research examined how long a measure of residual microbial activity (substantivity) could still be observed on the skin hours after application. Studies reported measured changes in bacterial counts in the observed populations, documenting the degree and duration of residual activity. However, the degree of microbial change measured in trials can vary based on the specific formulation, and it is not yet clear whether the measured reduction directly translates into preventing subsequent clinical infection.


Evidence for use in Pre-procedural Disinfection

A large body of evidence has been gathered from research exploring its use in clinical settings for patient preoperative skin preparation. Systematic Reviews and large Randomized Controlled Trials (RCTs) were evaluated in adult and pediatric patients (2 months old) undergoing various surgical procedures. Research examined this use by evaluating this preparation against other antiseptic agents commonly used in surgery.

Studies explored two main types of outcomes: measurements related to the occurrence of Surgical Site Infections (SSI) in the post-operative period and the immediate change in bacterial colonization at the procedural site prior to incision. Studies reported measured changes in bacterial colonization at the skin surface compared to baseline measures. However, when monitoring the occurrence of SSI, findings varied across different types of surgical procedures included in the research.


Evidence for Supportive Use in Superficial Skin Issues

Pyoderm was studied for its role in the supportive management of superficial skin issues, such as conditions characterized by periods of heightened symptom activity like pustules and crusting. The research exploring this specific dermatological setting includes small-scale randomized trials and comparative studies. Studies monitored clinical sign scores, which are measurements that track the severity and extent of visible manifestations over a specific period.

However, the evidence is limited for this indication. Sample sizes were modest in many trials, and follow-up durations were limited, typically covering only the acute treatment phase. The reliance on extrapolation from general antiseptic research means the level of certainty remains low for this specific dermatological use.

Key Studies & References

  1. DailyMed Labeling: Chlorhexidine Gluconate Antiseptic Skin Cleanser, Solution

Frequently Asked Questions (FAQ)

Common questions about Pyoderm (FAQ)

Q: Does Pyoderm interact with common pain relievers like ibuprofen?

A: Official regulatory documents for Pyoderm's active ingredient report an absence of systemic pharmacokinetic interactions. This means that due to minimal topical absorption, interference with systemic oral medicines, such as Ibuprofen, is not typically anticipated. However, official information does not list every possible drug interaction.

Patients are generally advised to inform a healthcare professional about all medicines being used, including non-prescription pain relievers.


Q: Are there any skin care products I should avoid while using Pyoderm?

A: The active ingredient in Pyoderm is chemically incompatible with anionic agents, which includes common soaps and anionic surfactants found in many skin care products. Regulatory warnings indicate that products containing anionic components should be avoided near the application site, as this incompatibility can reduce Pyoderm's efficacy.


Q: Can I use Pyoderm while also taking oral antibiotics?

A: Regulatory documents primarily focus on the absence of systemic pharmacokinetic interactions with topical use, indicating minimal bloodstream absorption which generally minimizes interference with oral medications.

Patients are generally advised to inform a healthcare provider that they are using this topical product if they are also prescribed an oral antibiotic.


Q: Is Pyoderm safe to use on a child's face?

A: The product is generally approved for use in children 2 months of age and older. Official labeling specifies that the solution should be kept out of sensitive areas, including the eyes and mouth, and must not be used as a preoperative skin preparation on the head or face.

If use on a child’s face is being considered for general cleansing, seeking guidance from a healthcare professional regarding appropriate application is recommended.


Q: What if Pyoderm gets into my eyes?

A: Official product instructions emphasize that the liquid must be kept out of the eyes and other sensitive areas. If accidental exposure occurs, standard care instructions for similar products advise rinsing the affected area thoroughly with water.

If irritation or vision changes persist following rinsing, seeking medical attention is generally recommended.


Q: Can Pyoderm be used under bandages or dressings?

A: For pre-operative uses, official protocols require the preparation to be allowed to air dry completely before the site is covered. For general use, application should follow the 'minimum amount necessary' principle.

If covering the treated area with a bandage or dressing is being considered, review of the specific product label or discussion with a healthcare provider is necessary, especially if the skin is damaged.


Q: Can Pyoderm be used on open wounds or cuts?

A: Regulatory labeling advises that Pyoderm must not be used on deep or puncture wounds. The product is intended for external use on the skin's surface for its antiseptic and germicide function.

If a wound is deeper than the superficial layers of skin, seeking guidance from a healthcare professional is necessary to determine the appropriate care.


Q: What are the general recommendations for using Pyoderm on large areas of skin?

A: The general instruction for skin cleansing is to apply only the minimum amount necessary to fully cover the targeted area and then rinse. This principle is emphasized over using large volumes.

In general, applying the minimal amount necessary helps limit overall exposure.


Q: Does applying too much Pyoderm increase the risk of side effects?

A: Applying more than the minimum amount necessary may increase the potential for localized side effects such as skin irritation, and the product's safety information notes a risk of chemical burn. Adherence to the recommended minimal application amount is generally advised to reduce the potential for adverse skin reactions.


Q: Can Pyoderm be used on eczema that has become infected?

A: Clinical studies have explored its role in the supportive management of superficial skin issues characterized by pustules and crusting. However, specific regulatory approval for the use of Pyoderm on eczema itself is generally not granted.

For any specific infected skin condition, including eczema, consultation with a healthcare professional is necessary to determine appropriate management.


Q: Are there any common mild side effects of Pyoderm that people report?

A: Official post-marketing surveillance reports on the active ingredient indicate that common mild effects include localized skin reactions such as irritation, redness, or a rash at the application site.

These are reported in addition to the rare, serious systemic allergic reactions listed in regulatory documents.


Q: What should I do if my skin gets red or itchy after applying Pyoderm?

A: Official safety warnings indicate that if irritation, increased redness, or signs of sensitization occur, the product's use should be discontinued.

These symptoms may suggest a more serious reaction. If symptoms persist or worsen, guidance from a healthcare professional should be sought.


Q: Can Pyoderm cause any systemic side effects?

A: Absorption from the topical application is considered minimal. However, the regulatory labeling does include a rare but serious systemic side effect: anaphylaxis.

Anaphylaxis is a severe, widespread allergic reaction that is potentially life-threatening and may include symptoms such as wheezing, trouble breathing, or facial swelling.


Q: Can Pyoderm be used for fungal infections too?

A: The active ingredient in Pyoderm is classified as a broad-spectrum antimicrobial agent. Official information confirms that it demonstrates activity against various microorganisms, including both bacteria and some yeasts (fungi).

Its intended function is to leverage this activity for antiseptic purposes on the skin.


Q: Does Pyoderm interact with multivitamin supplements?

A: Regulatory documents indicate that the topical application route results in minimal systemic absorption, leading to an absence of systemic pharmacokinetic interactions.

As a general safety measure, all patients are encouraged to tell their health provider about all therapies they are using, including supplements.


Q: Why is Pyoderm considered a narrow-spectrum or broad-spectrum antibiotic?

A: Pyoderm's active ingredient, Chlorhexidine Gluconate, is recognized for its broad-spectrum antimicrobial activity. This means it is effective against a wide range of different types of bacteria and other microorganisms.

This broad activity is a key feature that supports its use as an antiseptic.


Q: Does Pyoderm interact with herbal remedies like St. John's Wort?

A: Due to its topical route and minimal systemic absorption, the product is not expected to cause systemic interactions with oral medications or supplements, including herbal remedies like St. John's Wort.

Nevertheless, patients are generally advised to share a full list of all products they are using with their healthcare provider.


Q: What's the difference in how Pyoderm works compared to an antiseptic wash?

A: Pyoderm's active ingredient works through a rapid physical-chemical process by disrupting the cell membranes of microorganisms. A key difference from many traditional antiseptic washes is its substantivity.

Substantivity is the compound's ability to adhere to the skin, which allows the antiseptic activity to be sustained for a notable period after the initial rinse, unlike agents with only immediate effects.


Q: Have there been any major product recalls or safety alerts for Pyoderm?

A: Official regulatory bodies have issued warnings related to the active ingredient, Chlorhexidine Gluconate, which include alerts about the potential for rare but serious allergic reactions.

Safety alerts have included statements regarding the risk of chemical burns, particularly when the product is used in certain high-risk populations such as premature infants.

How should Pyoderm be stored and disposed of?

Pyoderm (Chlorhexidine Gluconate topical) must be stored strictly according to regulatory labeling to maintain stability.

Required Storage Conditions

Storage must be at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F). The product must be kept from freezing and protected from excessive heat. It is also mandatory to Protect from light and keep the container tightly closed when not in use. For safety, the product must be stored out of the reach of children.


Official Disposal Rules

Unused or expired product must be disposed of following local regulations. It is explicitly required to avoid release to the environment and not let the product enter drains or sewage systems. Single-use wipes or cloths must be discarded after a single use and should NOT be flushed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pyoderm found in:

A-Z Index: